MyFinsight
Home
Blog
About
Propanc Biopharma, Inc. (PPCB)
Propanc Biopharma, Inc. (PPCB)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$117,535
Free Cash flow
-$1,142,600
Unit: Dollar
Positive Cash Flow Breakdown
Common stock issuable for servic...
Amortization of prepaid stock ba...
Proceeds from exercise of series...
Others
Negative Cash Flow Breakdown
Net loss
Change in fair value of warrant ...
Prepaid expenses
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net loss
-6,360,336
-3,091,394
-4,837,738
-58,923,300
Issuance of common stock for services
7,500
7,500
726,248
51,348,000
Common stock issuable for services
3,570,000
-
-
-
Amortization of prepaid stock based expenses
1,773,636
2,471,762
3,024,605
4,621,230
Foreign currency transaction loss
35,006
-19,497
-34,699
-89,243
Refundable advance deposit
-
-
-
0
Depreciation expense
316
229
125
0
Deferred offering costs
-
-
-
0
Amortization of debt discounts
11,585
35,875
150,902
303,563
Derivative expense
-
-
-
333,596
Amortization of right-of-use assets
6,270
5,803
3,577
20,187
Change in fair value of derivative liabilities
-18,146
87,728
-19,706
212,450
Change in fair value of warrant liability
-182,517
-593,710
-
-
Loss (gain) on extinguishment of debt, net
-74,235
14,317
195,861
-871,032
Allowance on refundable advance deposit
-
-
-
0
Non-cash interest expense
0
937
4,906
5,519
Accretion of put premium
0
0
-37,450
0
Gst receivable
-6,111
8,572
3,043
2,405
Prepaid expenses
40,079
-333,739
362,329
-1,379
Other current assets
26,221
-
7,438
-
Accounts payable
-24,867
-123,564
-186,804
187,732
Employee benefit liability
13,042
11,549
13,982
40,184
Accrued expenses and other payables
42,880
9,816
-361,479
677,889
Accrued interest
15,512
22,151
-3,298
255,155
Operating lease liability
-5,215
-6,151
2,723
-21,722
Net cash used in operating activities
-1,142,446
-999,140
-1,939,067
-405,168
Purchase of equipment
154
2,267
2,491
-
Proceeds from loans payable
-
-
-
0
Net cash used in investing activities
-154
-2,267
-2,491
-
Proceeds from convertible promissory notes, net of original issue discounts and issue costs
0
0
100,000
222,500
Proceeds from issuance of convertible series c preferred stock, net of issuance cost
0
950,099
-
-
Proceeds from exercise of series c warrants
1,000,000
-
-
-
Repayment of convertible notes
0
0
203,350
8,000
Repayment of notes
0
0
671,777
122,788
Repayment of loans payable - related party
18,386
0
150,808
-
Proceeds from the sale of common stock, net of offering costs
0
0
3,314,458
0
Proceeds from note payable
0
0
75,000
320,000
Proceeds from loans payable - related parties
0
0
78,249
343,700
Deferred offering costs
-
-
15,000
264,656
Net cash provided by financing activities
981,614
965,099
2,526,772
490,756
Effect of exchange rate changes on cash
43,451
-5,192
5,435
-94,585
Net increase in cash
-117,535
-41,500
590,649
-8,997
Cash at beginning of period
602,737
602,737
12,088
21,085
Cash at end of period
443,702
561,237
602,737
12,088
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from exercise of
series c warrants
$1,000,000
Net cash provided by
financing activities
$981,614
Effect of exchange rate
changes on cash
$43,451
Canceled cashflow
$18,386
Net increase in cash
-$117,535
Canceled cashflow
$1,025,065
Common stock issuable
for services
$3,570,000
Amortization of prepaid stock
based expenses
$1,773,636
Loss (gain) on
extinguishment of debt, net
-$74,235
Accrued expenses and
other payables
$42,880
Change in fair value of
derivative liabilities
-$18,146
Accrued interest
$15,512
Employee benefit
liability
$13,042
Amortization of debt
discounts
$11,585
Issuance of common stock
for services
$7,500
Amortization of right-of-use
assets
$6,270
Gst receivable
-$6,111
Depreciation expense
$316
Repayment of loans payable
- related party
$18,386
Net cash used in
operating activities
-$1,142,446
Canceled cashflow
$5,539,233
Net cash used in
investing activities
-$154
Net loss
-$6,360,336
Change in fair value of
warrant liability
-$182,517
Prepaid expenses
$40,079
Foreign currency
transaction loss
$35,006
Other current assets
$26,221
Accounts payable
-$24,867
Operating lease liability
-$5,215
Purchase of equipment
$154
Buy us a coffee